Novo Nordisk A/S (B Shares) ADRhedged (NVOH) Performance
NVOH total return
Distributions reinvested · as of Oct 23, 2026- YTD
- −15.9% since Dec 31, 2025
- 1 year
- −18.9% total return
- Since first price
- −52.1% since 2025
NVOH trailing returns vs SPY, QQQ, AGG
| Period | NVOH total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | +3.5% | +3.5% | −1.0% | −5.0% | +0.9% |
| 3 months | −16.2% | −16.3% | +3.2% | +1.9% | −0.4% |
| 6 months | +7.1% | +3.6% | +7.8% | +8.4% | −1.5% |
| YTD | −15.9% | −19.7% | +12.3% | +15.1% | −1.0% |
| 1 year | −18.9% | −24.0% | +14.4% | +15.9% | −1.1% |
| Since inceptionJan 7, 2025 | −52.1% | −55.3% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: NVOH vs SPY
From Jan 7, 2025: NVOH grew to $4,793, SPY to $13,164.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
NVOH returns by calendar year
2026 is year to date.
NVOH annual returns table
| Year | NVOH | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | −15.9% | −40.9% | +12.3% | +15.1% | −1.0% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
NVOH largest drawdowns
Now 55.8% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Feb 28, 2025 | −61.6% | Mar 27, 2026 | not yet | 1.1 years | 1.6 years so far |
| Jan 10, 2025 | −11.3% | Feb 14, 2025 | Feb 24, 2025 | 35 days | 45 days |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
NVOH risk statistics
| Statistic | Since 2025 |
|---|---|
| Annualized return | −37.5% |
| Volatility (annualized) | 49.7% |
| Sharpe ratio | -0.74 |
| Sortino ratio | -0.83 |
| Best month | +17.4% |
| Worst month | −36.1% |
| Best 12 months | +3.8% |
| Worst 12 months | −61.3% |
| Positive months | 45% |
| Beta vs S&P 500 | — |
| Correlation with S&P 500 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
NVOH rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 10 | −61.3% | −29.2% | +3.8% | 10% |
Every holding period starting at a month-end since 2025. Returns for 3 years and longer are annualized.
NVOH performance overview
Novo Nordisk A/S (B Shares) ADRhedged (NVOH) returned −18.9% over the past year, with distributions reinvested. Since its first recorded price on Jan 7, 2025 it has returned −52.1%. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −61.6%, from Feb 28, 2025 to Mar 27, 2026; the fund has not yet regained that high. Volatility has been 49.7% a year.
Related: NVOH chart, NVOH dividends. See the NVOH overview for the latest quote and fund facts.
NVOH performance FAQ
What is the NVOH return over the past year?
NVOH returned −18.9% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it fell 24.0%.
How much would $10,000 invested in NVOH be worth?
$10,000 invested in NVOH at its first recorded close on January 7, 2025 would be worth about $4,793 on October 23, 2026 with distributions reinvested.
What is the biggest drawdown of NVOH?
The largest peak-to-trough decline was −61.6% between February 28, 2025 and March 27, 2026. It has not yet recovered to that high; it is 55.8% below its peak.
How volatile is NVOH?
Over the past history NVOH had an annualized volatility of 49.7% and a Sharpe ratio of -0.74 (excess return over 1–3 month T-bills per unit of risk).